Cart
sales@molnova.com
Diphenhydramine hydrochloride
CAS No. 147-24-0
Diphenhydramine hydrochloride( DPH )
Catalog No. M12021 CAS No. 147-24-0
Diphenhydramine HCl (Benadryl), a histamine H1 antagonist used as an antiemetic, antitussive.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 31 | In Stock |
|
| 200MG | 43 | In Stock |
|
| 500MG | 52 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDiphenhydramine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionDiphenhydramine HCl (Benadryl), a histamine H1 antagonist used as an antiemetic, antitussive.
-
DescriptionDiphenhydramine HCl (Benadryl), a histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations.
-
In Vitro——
-
In Vivo——
-
SynonymsDPH
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorH1 receptor
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number147-24-0
-
Formula Weight291.82
-
Molecular FormulaC17H22ClNO
-
Purity>98% (HPLC)
-
SolubilityEthanol: 58 mg/mL (198.75 mM); Water: 58 mg/mL (198.75 mM); DMSO: 58 mg/mL (198.75 mM)
-
SMILESCl.CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Piao H, et al. Vascul Pharmacol. 2007 Apr;46(4):260-70.
molnova catalog
related products
-
Linetastine
Linetastine (TMK-688) is a 5-lipoxygenase inhibitor (5-LOX) that inhibits leukotriene production and antagonizes the effects of histamine.Linetastine is used in studies of asthma, atherosclerosis, and peptic ulcers.
-
KSK94
KSK94 is a specific H3 receptor antagonist that inhibits H3, sigma-1, and sigma-2 receptors , with Ki values of 7.9, 2958, and 75.2 nM, respectively, and can be used to study injurious pain and neuropathic pain.
-
Doxylamine succinate
Doxylamine succinate competitively inhibits histamine at H1 receptors with substantial sedative and anticholinergic effects.
